FOXR2 and cancer: FOXR2 dysregulation is involved in many aspects of cancer progression, such as altering oncogenic pathways, escaping apoptosis, enhancing drug resistance, inducing autophagy, facilitating epithelial to mesenchymal transition, improving DNA repair, and modifying cancer stem cell properties (Fig. 2).